Potato late blight costs European farmers an estimated EUR 1.9 billion annually. The disease -- caused by the oomycete Phytophthora infestans -- triggered the Irish famine in the 1840s and remains one of the most destructive crop pathogens on the planet. For the past century, the primary defence has been chemical fungicides, applied liberally and repeatedly throughout the growing season. That approach is under siege.

Danish agri-tech spinout Mycoverse has raised EUR 2.4 million in pre-seed funding to develop biological alternatives to those chemical pesticides, using fungi as the active ingredient. The round was co-led by Future Food Fund and High-Tech Grunderfonds (HTGF), with participation from PINC, the venture arm of Finnish food group Paulig.

The funding will support two years of field trials aimed at proving that Mycoverse's fungal-based bioactives can match or exceed the performance of chemical fungicides in real-world growing conditions. If the trials succeed, the company will be positioned to tap into a regulatory tailwind that is reshaping European agriculture from the ground up.

You cannot understand Mycoverse's timing without understanding the regulatory pressure bearing down on European agriculture. The EU's Farm to Fork strategy calls for a 50 percent reduction in chemical pesticide use by 2030. Several member states have already banned or restricted key active ingredients. France, Germany, and the Netherlands are phasing out substances that farmers have relied on for decades.

For potato farmers specifically, the regulatory squeeze is acute. Late blight management typically requires 10 to 15 fungicide applications per season, making it one of the most chemically intensive crops in European agriculture. As regulators remove approved substances from the market, farmers face a stark choice: find biological alternatives or accept higher crop losses.

That gap between regulatory ambition and on-farm reality is exactly where Mycoverse is positioned. The company's approach -- using naturally occurring fungi to suppress pathogens -- aligns with both the policy trajectory and the growing consumer demand for pesticide-free food.

Mycoverse is a spinout from the Technical University of Denmark (DTU), one of Europe's leading research institutions in biotechnology and agricultural science. Co-founders Svend Petersen (CEO) and Niels Bjerg Jensen built the company around a three-pillar technology platform: AI-driven strain discovery, advanced fungal production technology, and formulation science that ensures the bioactives survive field conditions.

The AI component is critical. Traditional biological crop protection has been hampered by the sheer complexity of fungal biology -- there are millions of potential strains, and only a tiny fraction produce compounds that are effective against specific pathogens. Mycoverse uses machine learning to screen and prioritize candidate strains, dramatically accelerating the discovery timeline compared to conventional methods.

The company's lead candidates have already demonstrated strong performance in greenhouse trials, showing efficacy against late blight comparable to synthetic fungicides. The EUR 2.4 million in pre-seed funding will now take those candidates into the field, where they will face the full complexity of weather, soil conditions, and pathogen pressure across multiple European growing regions.

The investor syndicate behind Mycoverse brings both deep pockets and domain expertise. HTGF (High-Tech Grunderfonds) is Germany's most active seed investor, with a portfolio spanning deeptech, biotech, and cleantech. Future Food Fund, backed by Dutch agri-food industry players, specializes in food system innovation. PINC, Paulig's venture arm, brings a direct connection to the food value chain.

The strategic logic for each investor is clear. HTGF sees Mycoverse as a deeptech bet on biological manufacturing -- the same platform that produces crop protection bioactives could eventually produce compounds for pharmaceutical, food, and industrial applications. Future Food Fund views it through the lens of food system sustainability. And Paulig, through PINC, gains early access to technology that could reshape the supply chains feeding its consumer food brands.

While potato late blight is the initial target, Mycoverse's platform is designed to extend across crops and pathogens. The company has indicated that grapevines are a likely second application, where fungal diseases like downy mildew cause significant economic losses and chemical treatments face similar regulatory headwinds.

The platform play is what makes Mycoverse interesting beyond its immediate product pipeline. If the AI-driven discovery engine can reliably identify effective fungal strains for one pathogen, the same methodology can be applied to dozens of others. Each new crop-pathogen combination represents a distinct market opportunity with its own regulatory pathway and commercial potential.

This is the vision that pre-seed investors are buying into: not a single product, but a platform for systematically replacing chemical crop protection with biological alternatives. If the field trials validate the approach, the next round of funding will be significantly larger -- and the competitive dynamics in the EUR 2.5 billion European biologicals market will shift accordingly.

Europe is dismantling its chemical pesticide infrastructure without a clear replacement. Mycoverse, born in a Danish university lab and backed by investors who understand both the science and the market, is racing to fill that gap. EUR 2.4 million is modest by venture standards, but the field trial results it will fund over the next two years could prove transformative for how the continent feeds itself.